Physician

Joshua Bharat Sundhar, MD

According to 2025 Medicare claims, Joshua Sundhar, MD (NPI: 1760623193) practices rheumatology in the Camden, NJ market, with the plurality of this provider's patient population coming from Gloucester, NJ. This provider's primary affiliated billing organization is TRABECULAR MEDICAL GROUP, LLC (NPI: 1427622661; TIN: 851604336) and primary practice location at 08080-3552.

Sundhar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 559 traditional Medicare patients, billed 113,143 HCPCS/CPT codes, and received $1,151,717 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,675 prescription claims across 494 beneficiaries totaling $2,861,367 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). 2017 DME data shows 12 claims. Open Payments data shows 26 records totaling $17,829. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,143,497 to $2,861,367. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	659	54,550	$1,275,298
2016	660	61,581	$1,272,326
2017	687	73,427	$1,461,282
2018	798	71,124	$1,345,799
2019	741	91,523	$1,525,707
2020	675	103,878	$1,621,984
2021	651	102,575	$1,389,817
2022	619	109,483	$1,388,413
2023	527	84,868	$1,095,493
2024	559	113,143	$1,151,717

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	426	2,174	$1,143,497
2016	444	2,271	$1,307,281
2017	490	2,560	$1,437,129
2018	517	2,650	$1,761,095
2019	519	2,587	$2,108,409
2020	481	2,617	$2,376,727
2021	518	2,671	$1,750,771
2022	495	2,587	$1,888,234
2023	482	2,604	$2,171,552
2024	494	2,675	$2,861,367

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$72
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	83	163	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	253	451	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	131	190	$76
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	97	318	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	280	423	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Sensoready (2 Pens)	Secukinumab	46	1,680	$461,960
Enbrel Sureclick	Etanercept	40	1,596	$410,514
Skyrizi Pen	Risankizumab-Rzaa	14	1,126	$290,206
Humira(Cf) Pen	Adalimumab	31	1,148	$274,991
Enbrel	Etanercept	28	784	$201,508

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$1,528	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$16,301	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joshua Bharat Sundhar, MD?

Tedicare shows public-source Medicare data for Joshua Bharat Sundhar, MD (NPI 1760623193), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Bharat Sundhar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Bharat Sundhar, MD?

Joshua Bharat Sundhar, MD is linked to TRABECULAR MEDICAL GROUP, LLC (billing NPI 1427622661) in the available physician profile data.

Does Joshua Bharat Sundhar, MD have Open Payments data?

Joshua Bharat Sundhar, MD has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.